Dopamine oxidation Merchandise as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson’s Sickness.
The preferential degeneration of dopaminergic neurons inside the substantia nigra pars compacta is accountable for the motor impairment associated to Parkinson’s sickness. Dopamine is a extraordinarily reactive molecule, which is often saved inside synaptic vesicles the place it is stabilized by the ambient low pH.
Nonetheless, free cytosolic dopamine can auto-oxidize, producing reactive oxygen species, and end result within the formation of toxic quinones. Throughout the present work, we’ve got now analyzed the mechanisms by the use of which the dysfunction of dopamine homeostasis might induce cell toxicity, by focusing particularly on the hurt induced by dopamine oxidation merchandise on the mitochondrial diploma.
Our outcomes level out that dopamine derivatives impact mitochondrial morphology and induce mitochondrial membrane depolarization, leading to a reduction of ATP synthesis. Moreover, our outcomes counsel that opening of the mitochondrial transition pore induced by dopamine-derived quinones may contribute to the exact Parkinson’s disease-associated vulnerability of dopamine containing neurons.
OPEF01337-25ML - Epstein-Barr Virus (EBV) Negative Control Extract |
|||
| OPEF01337-25ML | Aviva Systems Biology | 25ml | EUR 2901 |
Epstein-Barr Virus (EBV) Capsid Antigen P18, alternative buffer Control Antigen |
|||
| BA1361R01 | Genovis AB | 1 mg | EUR 800 |
NATtrol Epstein Barr Virus (EBV) Strain: B95-8 (Linearity Panel (6 X 0.5 mL) |
|||
| NATEBV-LIN | Zeptometrix | 6 X 0.5 mL | EUR 657 |
genesig Easy kit for Epstein Barr Virus (HHV4) |
|||
| Z-Path-EBV-EASY | Novacyt Group | 50 tests | EUR 410 |
|
Description: EBV |
|||
CLIA Kit for Epstein Barr Virus Induced Protein 3 (EBI3) |
|||
| SCD206Hu | Cloud-Clone | 96Т | EUR 840 |
CLIA Kit for Epstein Barr Virus Induced Protein 3 (EBI3) |
|||
| SCD206Mu | Cloud-Clone | 96Т | EUR 864 |
ELISA Kit for Epstein Barr Virus Induced Protein 3 (EBI3) |
|||
| SED206Mu | Cloud-Clone | 96Т | EUR 720 |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Insect Cell Lysate (WB positive control) |
|||
| MBS8116007-03mg | MyBiosource | 0.3mg | EUR 280 |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Insect Cell Lysate (WB positive control) |
|||
| MBS8116007-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 HEK293 Cell Lysate (WB positive control) |
|||
| MBS8116008-03mg | MyBiosource | 0.3mg | EUR 280 |
Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 HEK293 Cell Lysate (WB positive control) |
|||
| MBS8116008-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
ELISA kit for Mouse EBI3 (Epstein Barr Virus Induced Protein 3) |
|||
| ELK6316 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Epstein Barr Virus Induced Protein 3 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Epstein Barr Virus (EBV) |
|||
| GWB-BCFC81 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus (EBV) |
|||
| MBS655263-1mg | MyBiosource | 1mg | EUR 825 |
Epstein Barr Virus (EBV) |
|||
| MBS655263-5x1mg | MyBiosource | 5x1mg | EUR 3480 |
Mouse antibody for Epstein-Barr virus |
|||
| 0223 | Virostat | 100 ug | EUR 431.93 |
|
Description: This is Mouse monoclonal FITC conjugated antibody against Epstein-Barr virus gp 250/350 for WB, ELISA. |
|||
Epstein Barr Virus Antibody |
|||
| GWB-243340 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus Antibody |
|||
| GWB-378AD4 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus Antibody |
|||
| GWB-C4E88B | GenWay Biotech | 0.1 mg | Ask for price |
MAb to Epstein Barr Virus |
|||
| MBS310152-1mg | MyBiosource | 1mg | EUR 1270 |
MAb to Epstein Barr Virus |
|||
| MBS310152-5x1mg | MyBiosource | 5x1mg | EUR 5550 |
MAb to Epstein Barr Virus |
|||
| MBS310154-1mg | MyBiosource | 1mg | EUR 1270 |
MAb to Epstein Barr Virus |
|||
| MBS310154-5x1mg | MyBiosource | 5x1mg | EUR 5550 |
MAb to Epstein Barr Virus |
|||
| MBS310209-1mg | MyBiosource | 1mg | EUR 1270 |
MAb to Epstein Barr Virus |
|||
| MBS310209-5x1mg | MyBiosource | 5x1mg | EUR 5550 |
MAb to Epstein Barr Virus |
|||
| MBS310210-01mg | MyBiosource | 0.1mg | EUR 640 |
MAb to Epstein Barr Virus |
|||
| MBS310210-5x01mg | MyBiosource | 5x0.1mg | EUR 2715 |
MAb to Epstein Barr Virus |
|||
| MBS310341-1mg | MyBiosource | 1mg | EUR 670 |
MAb to Epstein Barr Virus |
|||
| MBS310341-5x1mg | MyBiosource | 5x1mg | EUR 2835 |
Epstein Barr Virus (VCA) IgM |
|||
| GWB-F67BD1 | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus (VCA) IgG |
|||
| GWB-F14231 | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus, LMP-1 |
|||
| MBS370066-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Epstein Barr Virus (EBNA) IgG |
|||
| GWB-5ED61E | GenWay Biotech | 1x96 Assays | Ask for price |
Epstein Barr Virus (EBV-VCA) |
|||
| GWB-A7992B | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus (EBV) Antigen |
|||
| MBS655110-1mL | MyBiosource | 1mL | EUR 820 |
Epstein Barr Virus (EBV) Antigen |
|||
| MBS655110-5x1mL | MyBiosource | 5x1mL | EUR 3470 |
Epstein Barr Virus, (EBV) Antibody, Concentrate |
|||
| MAB875C | Innovex | 0.2ml | EUR 425 |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-5378B2 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-B44091 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus Antibody (LMP) |
|||
| GWB-1DCE8E | GenWay Biotech | 1 ml | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-91C835 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-949360 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBV), Antibody |
|||
| GWB-83E7C8 | GenWay Biotech | 0.2 mg | Ask for price |
Epstein Barr Virus (EBNA-nuclear) |
|||
| GWB-2F10DC | GenWay Biotech | 1 mg | Ask for price |
Goat polyclonal antibody for Epstein-Barr virus |
|||
| 277 | Virostat | 1 ml | EUR 360.16 |
|
Description: This is Biotin conjugated goat polyclonal antibody against Epstein-Barr virus EBNA-1 for WB, ELISA. |
|||
Epstein Barr Virus, env gp (EBV) |
|||
| MBS603798-02mg | MyBiosource | 0.2mg | EUR 535 |
Epstein Barr Virus, env gp (EBV) |
|||
| MBS603798-5x02mg | MyBiosource | 5x0.2mg | EUR 2255 |
Epstein Barr Virus Monoclonal Antibody |
|||
| MBS190144-01mg | MyBiosource | 0.1mg | EUR 315 |
Epstein Barr Virus Monoclonal Antibody |
|||
| MBS190145-01mg | MyBiosource | 0.1mg | EUR 315 |
Epstein Barr Virus (EBV), gp250/350 |
|||
| MBS6507448-01mg | MyBiosource | 0.1mg | EUR 710 |
Epstein Barr Virus (EBV), gp250/350 |
|||
| MBS6507448-5x01mg | MyBiosource | 5x0.1mg | EUR 3040 |
Epstein Barr Virus (EBV) EA-early |
|||
| GWB-89FE90 | GenWay Biotech | 1 mg | Ask for price |
Epstein Barr Virus gp125, Mouse Fc |
|||
| REC31601-100 | The Native Antigen Company | 0.1 | EUR 522.75 |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
|||
Epstein Barr Virus gp125, Mouse Fc |
|||
| REC31601-500 | The Native Antigen Company | 0.5 | EUR 1869.54 |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
|||
Epstein Barr Virus gp125, Human Fc |
|||
| REC31602-100 | The Native Antigen Company | 0.1 | EUR 522.75 |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
|||
Epstein Barr Virus gp125, Human Fc |
|||
| REC31602-500 | The Native Antigen Company | 0.5 | EUR 1869.54 |
|
Description: Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
|||
Epstein Barr Virus (EBV) Early Antigen |
|||
| BA1363P54VS | Genovis AB | 1mg | EUR 1138 |
Epstein Barr Virus (EBV) Early Antigen |
|||
| BA1363VSR6 | Genovis AB | 1mg | EUR 1138 |
Epstein Barr Virus (EBV) EBNA, Antibody |
|||
| GWB-53FBAA | GenWay Biotech | 0.2 mg | Ask for price |
Mouse antibody for Epstein-Barr virus VCA-gp |
|||
| 241 | Virostat | 100 ug | EUR 386.26 |
|
Description: This is purified Mouse monoclonal antibody against Epstein-Barr virus VCA-gp for WB, ELISA. |
|||
Epstein Barr Virus (EBV) Capsid Antigen |
|||
| BA1361VSR21 | Genovis AB | 1mg | EUR 1138 |
Epstein Barr Virus (EBV) Capsid Antigen |
|||
| BA1361VSR22 | Genovis AB | 1mg | EUR 1138 |
Epstein Barr Virus, Early Antigen, zeta |
|||
| MBS600173-01mg | MyBiosource | 0.1mg | EUR 580 |
Epstein Barr Virus, Early Antigen, zeta |
|||
| MBS600173-5x01mg | MyBiosource | 5x0.1mg | EUR 2470 |
Epstein Barr Virus (EBV) Nuclear Antigen |
|||
| BA1362VS | Genovis AB | 1mg | EUR 1138 |
Epstein Barr Virus, Nuclear Antigen (EBV) |
|||
| MBS624641-1mL | MyBiosource | 1mL | EUR 1000 |
Epstein Barr Virus, Nuclear Antigen (EBV) |
|||
| MBS624641-5x1mL | MyBiosource | 5x1mL | EUR 4345 |
Epstein Barr Virus (EBV), Nuclear Antigen |
|||
| MBS655143-1mg | MyBiosource | 1mg | EUR 825 |
Epstein Barr Virus (EBV), Nuclear Antigen |
|||
| MBS655143-5x1mg | MyBiosource | 5x1mg | EUR 3480 |
Epstein Barr Virus, env gp (EBV) (AP) |
|||
| MBS6260154-01mL | MyBiosource | 0.1mL | EUR 785 |
Epstein Barr Virus, env gp (EBV) (AP) |
|||
| MBS6260154-5x01mL | MyBiosource | 5x0.1mL | EUR 3380 |
Epstein Barr Virus, env gp (EBV) (PE) |
|||
| MBS6262705-01mL | MyBiosource | 0.1mL | EUR 785 |
Epstein Barr Virus, env gp (EBV) (PE) |
|||
| MBS6262705-5x01mL | MyBiosource | 5x0.1mL | EUR 3380 |
Epstein Barr Virus, env gp (EBV) (APC) |
|||
| MBS6260665-01mL | MyBiosource | 0.1mL | EUR 785 |
Epstein Barr Virus, env gp (EBV) (APC) |
|||
| MBS6260665-5x01mL | MyBiosource | 5x0.1mL | EUR 3380 |
Epstein Barr Virus, env gp (EBV) (HRP) |
|||
| MBS6262195-01mL | MyBiosource | 0.1mL | EUR 785 |
Epstein Barr Virus, env gp (EBV) (HRP) |
|||
| MBS6262195-5x01mL | MyBiosource | 5x0.1mL | EUR 3380 |
Epstein Barr Virus, EBNA1, Recombinant (EBV) |
|||
| MBS637565-01mg | MyBiosource | 0.1mg | EUR 845 |
Epstein Barr Virus, EBNA1, Recombinant (EBV) |
|||
| MBS637565-5x01mg | MyBiosource | 5x0.1mg | EUR 3660 |
Epstein Barr Virus (EBV), gp250/350 (PE) |
|||
| MBS6244340-01mL | MyBiosource | 0.1(mL | EUR 995 |
Epstein Barr Virus (EBV), gp250/350 (PE) |
|||
| MBS6244340-5x01mL | MyBiosource | 5x0.1mL | EUR 4325 |
Epstein Barr Virus, env gp (EBV) (FITC) |
|||
| MBS6261685-01mL | MyBiosource | 0.1mL | EUR 785 |
Epstein Barr Virus, env gp (EBV) (FITC) |
|||
| MBS6261685-5x01mL | MyBiosource | 5x0.1mL | EUR 3380 |
Epstein Barr Virus (EBV), gp250/350 (AP) |
|||
| MBS6241676-01mL | MyBiosource | 0.1(mL | EUR 995 |
Epstein Barr Virus (EBV), gp250/350 (AP) |
|||
| MBS6241676-5x01mL | MyBiosource | 5x0.1mL | EUR 4325 |
Epstein Barr Virus (EBV), gp250/350 (HRP) |
|||
| MBS6243807-01mL | MyBiosource | 0.1(mL | EUR 995 |
Inhibition of superior glycation end merchandise by isoferulic acid and its free radical scavenging functionality: An in vitro and molecular docking study.
Non-enzymatic glycation and Oxidation of some vital natural macromolecules are paramount inside the pathogenesis of various sicknesses along with diabetes and atherosclerosis.
- Hyperglycemia performs a key perform inside the pathological technique of diabetic issues by progressive accumulation of superior glycation end merchandise (AGEs) in physique tissues. Formation of AGEs on account of protein glycation is adopted by an elevated free radical train that furthermore contributes in course of the bio-macromolecular hurt.
- The present study aimed to guage the free radical scavenging and antiglycation functionality of isoferulic acid (IFA). The free radical scavenging train of IFA was measured using DPPH, FRAP, and metal chelating assays. IFA confirmed environment friendly reducing vitality, free radical scavenging train and metal chelation train in focus dependent technique.
- The antiglycation train of IFA was studied using quite a few spectroscopic strategies. The obtained outcomes had been validated with free amino, sulfhydryl group, carbonyl content material materials and AGEs formation. Secondary structural alterations had been monitored using spherical dichroism, morphology of aggregates was analyzed using transmission electron microscopy.
- Molecular docking reveals the doable binding location of IFA with inside the sub-domain IIA of human serum albumin (HSA).
LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction analysis on degradation products of anagliptin.
Pharmaceutical medicine are potential molecules with explicit natural train. Nonetheless, long-term use of these chemical molecules can impact the human physiological system because of their elevated ranges inside the human physique. Resulting from this truth, identification and development elucidation of impurities or degradation merchandise must be thought of in order to ensure drug safety.
The present study assessed the degradation behaviour of dipeptidyl peptidase-4 (DPP-4) inhibitor anagliptin under completely completely different stress conditions as per ICH suggestions Q1A (R2) adopted by elucidation of the development of degradation merchandise. All the stress samples had been analysed by using UPLC/PDA.
The superior separation of drug from its degradation merchandise was attained with time programmed gradient elution on BEH C18 (100 mm × 2.1 mm, 1.7 μm) column using 10 mM ammonium formate (aqueous) and acetonitrile (pure) as a result of the cell half components.
All the degradation merchandise of anagliptin had been characterised using LC/QTOF/MS/MS. In addition to, the train and toxicity of degradation merchandise had been determined by the use of molecular docking and in silico toxicity prediction analysis, respectively. The developed UPLC/PDA approach was validated as per ICH suggestions on the subject of specificity, accuracy, precision, linearity and robustnes
Molecular Distributions of Soluble Oxidation Merchandise from Coals Characterised by Mass Spectrometers.
Oxidation of three coals with rank from lignite to anthracite in NaOCl aqueous reply was investigated on this study. The oxidation merchandise had been characterised by using gasoline chromatography/mass spectrometry and direct analysis in real-time mass spectrometry.
The outcomes confirmed that almost all of pure compounds in coals had been reworked into water-soluble species under delicate conditions, even the anthracite. Benzene polycarboxylic acids (BPCAs) and chloro-substituted alkanoic acids (CSAAs) had been most important merchandise from the reactions.
The merchandise from lower rank coals embody considerable CSAAs and most merchandise from extreme rank coals are BPCAs. As coal rank will enhance, the yield of BPCAs with additional carboxylic groups will enhance.
Flat Replaceable Tips 13 mm Diameter Flat Titanium Tip |
|||
| 0-120-0016 | Biologics | 13 mm | EUR 86 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 19 mm Diameter Flat Titanium Tip |
|||
| 0-120-0017 | Biologics | 19 mm | EUR 92 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Flat Replaceable Tips 25 mm Diameter Flat Titanium Tip |
|||
| 0-120-0018 | Biologics | 25 mm | EUR 100 |
|
Description: use with corresponding Tapped Tips and Tapped Extender Tips |
|||
Titanium Cup Tip, 250 ml |
|||
| 0-120-0019 | Biologics | 250 ml | EUR 1377 |
|
Description: includes Interface Washers |
|||
Microtube Tray, 8 Position (for 250 ml Cup Tip) |
|||
| 0-120-0021 | Biologics | each | EUR 113 |
|
Description: includes Interface Washers |
|||
Continuous Flow Chamber |
|||
| 0-120-0026 | Biologics | each | EUR 774 |
|
Description: includes Interface Washers |
|||
Interface Washers 1.5” Diameter, 5/Pkg |
|||
| 0-120-003 | Biologics | 1.5'' Diameter | EUR 31 |
13 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0032 | Biologics | 13 mm | EUR 301 |
13 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0033 | Biologics | 13 mm | EUR 362 |
19 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0034 | Biologics | 19 mm | EUR 315 |
19 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0035 | Biologics | 19 mm | EUR 375 |
25 mm Diameter Solid Titanium Extender Tip |
|||
| 0-120-0036 | Biologics | 25 mm | EUR 328 |
25 mm Diameter Tapped Titanium Extender Tip |
|||
| 0-120-0037 | Biologics | 25 mm | EUR 389 |
KoldPod, 1.5ml Micro Tube |
|||
| 0-120-0038 | Biologics | 1.5 ml | EUR 152 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 15ml Conical Tube |
|||
| 0-120-0039 | Biologics | 15 ml | EUR 275 |
|
Description: Thermo conductive tube pods |
|||
KoldPod, 50ml Conical Tube |
|||
| 0-120-0040 | Biologics | 50 ml | EUR 290 |
|
Description: Thermo conductive tube pods |
|||
Model 150 V/T Ultrasonic Homogenizer |
|||
| 0-121-0002 | Biologics | 210-240V/50-60Hz | EUR 2920 |
|
Description: Delivers up to 150 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample processing processing. |
|||
Model 300 V/T Ultrasonic Homogenizer |
|||
| 0-122-0002 | Biologics | 210-240V/50-60Hz | EUR 3520 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip. The Timer and Duty Cycle function increase preciosion in sample. |
|||
SONABOZ Sound Abating Chamber |
|||
| 0-125-0001 | Biologics | each | EUR 1020 |
|
Description: Reduces cavitational sound emitted during processing. |
|||
Model 3000 Ultrasonic Homogenizer |
|||
| 0-127-0002 | Biologics | 210-240V/50-60Hz | EUR 4120 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip and includes an intergrated Sound Abating Chmaber to reduce cavitational sound emitted during processing. The Timer and Duty Cycle function increase preciosion in sample. |
|||
Model 3000MP Ultrasonic Homogenizer |
|||
| 0-128-0002 | Biologics | 210-240V/50-60Hz | EUR 4720 |
|
Description: Delivers up to 300 Watts of ultrasonic power to the Titanium Tip with preciosion control from a microprocessor and a graphical user interface displayed on a large (145 mm) LCD display. The integrated Sound Abating Chamber reduces cavitational sound emitted during processing. |
|||
OMNICON® Zone Reader, 210-240V/50-60Hz |
|||
| 0-131-0002 | Biologics | 210-240V/50-60Hz | EUR 35200 |
|
Description: Designed to Perform multi-plate Assays on round 90/100mm Petri Dishes. The integrated LED illumination system provides transmitted light for brightfield and darkfield illumination of transparent media. |
|||
OMNI-Noculator Peni Cylinder Filler, 210-240V/50-60Hz |
|||
| 0-134-0002 | Biologics | 210-240V/50-60Hz | EUR 32200 |
|
Description: A robotic liquid handling system designed to dispense Peni Cylinders and fill Peni Cylinders with the corresponding antibiotic liquid sample. |
|||
Peni Cylinder Dispenser with Manual Hopper |
|||
| 0-144-0002 | Biologics | each | EUR 5406 |
|
Description: Dispenser can be configured to dispense 4 or 6 Peni Cylinders onto a petri dish. |
|||
Peni Cylinder Dispenser with Motorized Hopper, 100-240V/50-60Hz |
|||
| 0-144-0003 | Biologics | 100-240V/50-60Hz | EUR 6254 |
|
Description: The motorized hopper can be configured to dispense 4 or 6 Peni Cylinders onto a petri Dispenser can be disassembled for disinfection. |
|||
Stainless Steel Peni Cylinder with Flat Face |
|||
| 0-144-0005 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 399 |
|
Description: sold in packages of 100 pieces |
|||
Stainless Steel Peni Cylinder with Chamfered Face |
|||
| 0-144-0006 | Biologics | 6mm I.D. x 8mm O.D. x 10mm Long | EUR 412 |
|
Description: sold in packages of 100 pieces |
|||
Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA) |
|||
| 000-CUS | Alpha Diagnostics | Custom | EUR 602 |
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002 | Biotium | 1UG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-bungarotoxin, CF405s |
|||
| 00002 | Cusabio | 500uG | EUR 594 |
|
Description: Minimum order quantity: 1 unit of 500uG |
|||
Alpha-Bungarotoxin, CF®405S, 500 ug |
|||
| 00002-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®405S 100ug |
|||
| 00002-100ug | Biotium | 100uG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®680R, 500 ug |
|||
| 00003-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®680R 100ug |
|||
| 9-00003 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®640R, 500 ug |
|||
| 00004-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®640R 100ug |
|||
| 9-00004 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®488A, 500 ug |
|||
| 00005-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®488A 100ug |
|||
| 9-00005 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®568, 500 ug |
|||
| 00006-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®568 100ug |
|||
| 9-00006 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®594, 500 ug |
|||
| 00007-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin CF®594 100ug |
|||
| 9-00007 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®633, 500 ug |
|||
| 00009-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®633 100ug |
|||
| 9-00009 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
SARS-CoV-2 Indicator Cell Line for RNA Replication - GFP Reporter only |
|||
| 0001-PP-001 | IBT Bioservices | 1 cell line (can order x amount) | EUR 12000 |
|
Description: SARS-CoV-2 GFP reporter cell line using HEK293T (ACE2/TMPRSS2) cells |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1 | Biotium | 1MG | EUR 193 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, 1 mg |
|||
| 00010-1-1 | Biotium | EA | EUR 193 |
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011 | Biotium | 500uG | EUR 376 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-Alpha-Bungarotoxin, 500 ug |
|||
| 00011-1 | Biotium | EA | EUR 376 |
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012 | Biotium | 500uG | EUR 394 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-Alpha-Bungarotoxin, 500 ug |
|||
| 00012-1 | Biotium | EA | EUR 394 |
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013 | Biotium | 10ST | EUR 436 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Fluorescein-alpha-bungarotoxin, 10x50ug |
|||
| 00013-1 | Biotium | EA | EUR 436 |
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014 | Biotium | 10ST | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Tetramethylrhodamine-A-Bungarotoxin, 10x50 ug |
|||
| 00014-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015 | Biotium | 500uG | EUR 494 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 500 ug |
|||
| 00015-1 | Biotium | EA | EUR 494 |
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016 | Biotium | 10ST | EUR 560 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Sulforhodamine 101-Alpha-Bungarotoxin, 50 ug |
|||
| 00016-1 | Biotium | EA | EUR 560 |
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017 | Biotium | 500uG | EUR 455 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Biotin-XX-A-Bungarotoxin, 500 ug |
|||
| 00017-1 | Biotium | EA | EUR 455 |
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®555, 500 ug |
|||
| 00018-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®555 100ug |
|||
| 9-00018 | Biotium |
|
|
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-100 | Polysciences Europe GmbH | 100g | EUR 101.52 |
|
Description: 79-06-1 |
|||
Acrylamide, Chemzymes Ultra Pure® |
|||
| 00019-500 | Polysciences Europe GmbH | 500g | EUR 270 |
|
Description: 79-06-1 |
|||
Biotin-cAMP, 1 mg |
|||
| 00020 | Biotium | 1MG | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 1 mg |
|||
| 00020-1 | Biotium | 20ST | EUR 298 |
|
Description: N/A |
|||
Biotin-cAMP, 50 ug |
|||
| 00020-1-1 | Biotium | EA | EUR 414 |
Biotin-cGMP, 1 mg |
|||
| 00021 | Biotium | 1MG | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 1 mg |
|||
| 00021-1 | Biotium | 20ST | EUR 331 |
|
Description: N/A |
|||
Biotin-cGMP, 20x50 ug |
|||
| 00021-1-1 | Biotium | EA | EUR 447 |
Cyanine 644-cAMP, 1 mg |
|||
| 00022 | Biotium | 1MG | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 1 mg |
|||
| 00022-1 | Biotium | 20ST | EUR 496 |
|
Description: N/A |
|||
Cyanine 644-cAMP, 20x50 ug |
|||
| 00022-1-1 | Biotium | EA | EUR 647 |
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023 | Biotium | 1MG | EUR 285 |
|
Description: N/A |
|||
Fluorescein Methotrexate, Triammonium Salt, 1 mg |
|||
| 00023-1 | Biotium | EA | EUR 285 |
Staurosporine |
|||
| 00025 | Biotium | 100uG | EUR 100 |
|
Description: N/A |
|||
Staurosporine |
|||
| 00025-1 | Biotium | EA | EUR 100 |
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026 | Biotium | 500uG | EUR 527 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Alpha-Bungarotoxin, CF®543, 500 ug |
|||
| 00026-1 | Biotium | EA | EUR 527 |
Alpha-Bungarotoxin, CF®543, 100 ug |
|||
| 00026-100ug | Biotium | 1UG | EUR 132 |
|
Description: Alpha-bungarotoxin from Krait snake venom (Bungarus multicinctus) |
|||
Rhodamine Phalloidin 300U |
|||
| 00027 | Biotium | 300 | EUR 364 |
|
Description: N/A |
|||
Rhodamine Phalloidin 300U |
|||
| 00027-1 | Biotium | EA | EUR 364 |
Biotin-XX-Phalloidin |
|||
| 00028 | Biotium | 100U | EUR 466 |
|
Description: N/A |
|||
Biotin-XX-Phalloidin |
|||
| 00028-1 | Biotium | EA | EUR 466 |
Fluorescein-Phalloidin |
|||
| 00030 | Biotium | 300U | EUR 364 |
|
Description: N/A |
|||
Fluorescein-Phalloidin |
|||
| 00030-1 | Biotium | EA | EUR 364 |
Rhodamine 110 Phalloidin |
|||
| 00032 | Biotium | 300ST | EUR 364 |
|
Description: N/A |
|||
Rhodamine 110 Phalloidin |
|||
| 00032-1 | Biotium | EA | EUR 364 |
Sulforhodamine 101 (Texas Red®) Phalloidin |
|||
| 00033 | Biotium | 300EU | EUR 364 |
|
Description: N/A |
|||
Sulforhodamine 101 (Texas Red®) Phalloidin |
|||
| 00033-1 | Biotium | EA | EUR 364 |